Alpha Sense BI

MARCH 26, 2025

Hengrui has transitioned from a generic drug manufacturer to a major player in oncology, immunotherapy, and innovative treatments, investing heavily in global R&D infrastructure. Owned by Globe Fintech Innovations (Mynt), GCash has over 80 million users and dominates the countrys mobile payments, lending, and financial services space.

Commerce 52

Commerce Pharmaceutical Capital Biotech 52

Evalueserve

DECEMBER 6, 2021

Within the healthcare industry, healthcare equipment continues to outperform (refer to the graph below) driven by the urgent need for innovative care delivery in new or alternative settings and expedited recovery of demand especially for elective procedures. Sponsor deals rebounded exceptionally.

Capital 98

Capital Globalization Marketing Marketing 98

Alpha Sense BI

MAY 5, 2023

M&A Trends by Industry Healthcare The COVID-19 pandemic ushered in a wave of unprecedented innovation, progress, and transformation to the healthcare industry in 2020. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97

Biotech Capital Banking Startups 97

Sedulo

MARCH 15, 2023

Key Takeaways from the Assessment: While several insights were uncovered by analyzing trial clusters and the different IO drug modalities and sponsors, a few key takeaways from the data included: China emerging as innovation hub for IO therapies Smaller pharma/biotech conducting trials for emerging IO technologies Chinese and US small pharma/biotech (..)

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

Owler

MAY 17, 2023

Worldia’s product and the company’s resilience impressed investors like Credit Mutuel Innovation , who led the Series B funding round. Series A Funding Round Results in $59M for Taichu Biotech A China-based provider of drug development and evaluation services for the biopharmaceutical industry, Taichu Biotech raised $59M in funds.

Biotech 52

Biotech Travel Capital Entertainment 52

Alpha Sense BI

MAY 28, 2024

The top three trending sectors—information technology, healthcare/biotech, and business and financial services— ushered in funding rounds over $100 million since the beginning of the year. Instead, experts agree that investors will likely turn to innovative start-up companies with promising growth plans and strong leadership teams.

Capital 69

Capital Startups Biotech Due Diligence 69

Alpha Sense BI

AUGUST 30, 2023

Striking a balance between innovation and adherence to regulations is an ongoing priority that asset managers must stay attuned to. As AI systems play a larger role in investment decisions, transparency and explainability become crucial. Talent and Skill Shifts The integration of AI in asset management has led to a shift in required skills.

Management 98

Management Biotech Due Diligence Algorithm 98

BIS Research

MARCH 19, 2019

Precision medicine is an innovative approach to prevent and treat diseases by taking into account the individual distinction between genetic make-up, lifestyle, and environment of an individual. It is sometimes also known as personalized medicine.

Globalization 64

Globalization Biotech Marketing Marketing 64

Alpha Sense BI

APRIL 29, 2024

Instead, investors will likely turn to innovative start-up companies with promising growth plans and strong leadership teams. Sustainable startups are also gaining traction with VC investors for their innovative and potentially lucrative solutions. The renewable energy sub-sector is also seeing promising activity.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

APRIL 19, 2024

2020 and 2021 were marked by increased innovation, accelerated growth, and workforce expansion. Inflationary pressures are forecasted to ease and new innovations are capturing the attention of consumers, investors, and executives across various industries.

Technology 69

Technology Technology Retail Biotech 69

Alpha Sense BI

JANUARY 26, 2024

We believe that this focus on accessibility and sustainability represents an alternative and attractive opportunity in supporting innovative solutions for global healthcare challenges. This renewed interest in rare disease therapeutics can be attributed to the U.S.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

NOVEMBER 7, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?

Pharmaceutical 52

Pharmaceutical Biotech Innovation Technology 52

Engage3

MAY 19, 2022

Ken served on the Board of Directors of Revionics between 2007-2011 and as Chief Scientist & VP of Innovations at SAP AG between 2006-2007. Tim Ouimet Founder & Board Observer Tim Ouimet is a Founder and Board Member at Engage3 and is a recognized industry innovator in retail pricing strategies.

Retail 52

Retail Capital Finance Biotech 52

Wink Intel

FEBRUARY 23, 2021

tech and biotech ETFs and two fixed income components. With a twofold focus on technology, both in its design and in its equity thematic, this innovative index aims at providing investors with an opportunity for consistent performance across various market cycles.”.

Intellectual Property 40

Intellectual Property Banking Biotech Retail 40

Alpha Sense BI

JUNE 6, 2024

Whether you’re looking to refine your market strategy, innovate more effectively, or enhance your competitive advantage, mastering competitor analysis is your key to sustained success and growth. From there, you can strategically innovate to meet those precise needs and get an edge over your competitors.

Competitor Analysis 40

Competitor Analysis Analysis Battlecard SWOT 40

CIO

JULY 30, 2024

The launch of ChatGPT in November 2022 set off a generative AI gold rush, with companies scrambling to adopt the technology and demonstrate innovation. Some biotech and pharma companies, including Johnson & Johnson , are promoting gen AI as the next big thing in drug discovery.

Biotech 542

Biotech Business Pharmaceutical Finance 542

CIO

JULY 17, 2023

Many IT leaders today are focused more on security management as well as improving IT operations and systems performance than they are on top-line and strategic activities such as driving business innovation, identifying competitive differentiation opportunities, and even working on business strategy.

Biotech 370

Biotech Innovation Research Technology 370

CIO

MARCH 4, 2025

CEOs, CIOs and CFOs are finding that deep tech is actively driving business innovation and profitability. Biotechnology and synthetic biology: The swift development of mRNA vaccines in 2020 illustrated biotechs unprecedented speed in delivering transformative products. CRISPR) for personalized medicine and drought-resistant crops.

Technology 442

Technology Technology Biotech Business 442

CIO

NOVEMBER 25, 2024

I’ve had many great positions throughout my career, in many different industries, from biotech to pharma to tech software companies, and currently at a medical device company. But you need to balance the innovation with the risk that comes along with it. From the innovation lens, I’m excited about AI. Then I started working.

Biotech 458

Biotech Matrix Learning Security 458

Alpha Sense BI

MARCH 13, 2024

According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs. In January, HATCo announced its intent to acquire Summa Health of Ohio , a non-profit healthcare system, with a focus to “put innovation in.”

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 14, 2025

Biotech Funding Healthcare and biotech have experienced ongoing funding dryspells, with public funding down 56% for biotechnology companies in January of this year. However, according to broker research from the AlphaSense platform, robust VC funding helped offset an otherwise down month for biotech funding.

Capital 59

Capital Biotech Startups Finance 59

Alpha Sense BI

FEBRUARY 6, 2025

According to Synopsys, customers are feeling optimistic about the acquisition, as the combined company will be able to drive innovation across industries by addressing the growing need for integrated system design solutions. Leading broker research in the AlphaSense platform referred to it as the biggest software deal of 2024.

Biotech 59

Biotech Capital Pharmaceutical Finance 59

ATTEST

NOVEMBER 22, 2024

Boston’s innovation business ecosystem—from biotech startups in Kendall Square to fintech firms downtown—relies heavily on quality consumer insights. This modern approach aligns perfectly with Boston’s innovation-driven business culture.

Marketing Research 52

Marketing Research Market Research Research Marketing 52

ATTEST

DECEMBER 20, 2024

From biotech startups in Torrey Pines to craft breweries in North Park, San Diego businesses rely on solid consumer insights to guide their decisions. Attest – Best for fast, reliable consumer and market insights Attest revolutionizes market research through an innovative combination of advanced platform and expert research support.

Marketing Research 52

Marketing Research Market Research Research Marketing 52

Alpha Sense BI

JANUARY 8, 2025

At the same time, the outlook for therapeutic innovation remains bright. RFK), have clouded 2025 visibility for the healthcare sector and generated a mix of expectations for healthcare systems and providers, health insurers, and biotech/pharma companies. Kennedy Jr. What] makes it significantly worse is how the public reacted.

Innovation 69

Innovation Biotech Pharmaceutical Benchmarking 69